文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

跨性别成年人对当前激素治疗的满意度和对额外性别肯定护理的目标。

Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults.

机构信息

Department of Dermatology, School of Medicine, Emory University, Atlanta, GA 30322.

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, United States.

出版信息

J Sex Med. 2023 Mar 31;20(4):568-572. doi: 10.1093/jsxmed/qdad011.


DOI:10.1093/jsxmed/qdad011
PMID:36796861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10078937/
Abstract

BACKGROUND: Many transgender persons seek hormone therapy to reduce gender dysphoria and improve quality of life, but little is known about patient satisfaction with current gender-affirming hormone therapy. AIM: To examine patient satisfaction with current gender-affirming hormone therapy and patients' goals of additional hormone therapy. METHODS: Transgender adults in the validated multicenter STRONG cohort (Study of Transition, Outcomes, and Gender) were asked to complete a cross-sectional survey about current and planned hormone therapy and the effects that they experienced or hoped to gain. The proportion of respondents reporting overall satisfaction with hormone therapy were compared with χ2 or Fisher exact test. Cochran-Mantel-Haenszel analysis was used to compare the covariates of interest while controlling for age at the time of survey completion. OUTCOMES: Patient satisfaction across hormone therapies, each measured with a 5-point scale, was averaged and dichotomized. RESULTS: Out of 2136 eligible transgender adults, 696 (33%) completed the survey: 350 transfeminine (TF) and 346 transmasculine (TM) respondents. Most participants (80%) were satisfied or very satisfied with their current hormone therapies. TF participants and older participants were less likely to report being satisfied with their current hormone therapies than TM participants and younger participants, respectively. However, TM and TF categories were not associated with patient satisfaction after controlling for age at the time of survey completion. More TF persons planned to take additional treatment. The most frequent goals for additional hormone therapy for TF persons included breast size growth, feminine body fat distribution, and facial feature softening; for TM persons, goals included diminishing dysphoria, greater muscle mass, and masculine body fat distribution. CLINICAL IMPLICATIONS: Multidisciplinary care beyond provision of hormone therapy-such as involvement of surgical, dermatologic, reproductive health, mental health, and/or gender expression care-may be important to help achieve unmet gender-affirming care goals. STRENGTHS AND LIMITATIONS: This study had a modest response rate and included only respondents with private insurance, limiting generalizability. CONCLUSION: Understanding patient satisfaction and goals of care will assist shared decision making and counseling in patient-centered gender-affirming therapy.

摘要

背景:许多跨性别者寻求激素治疗以减少性别焦虑并提高生活质量,但目前关于患者对性别肯定激素治疗的满意度知之甚少。

目的:研究患者对当前性别肯定激素治疗的满意度以及患者对额外激素治疗的目标。

方法:在经过验证的多中心 STRONG 队列(过渡、结果和性别研究)中,要求跨性别成年人完成一项关于当前和计划中的激素治疗以及他们所经历或希望获得的治疗效果的横断面调查。使用 χ2 或 Fisher 确切检验比较报告总体激素治疗满意度的受访者比例。在控制调查完成时的年龄这一协变量的同时,使用 Cochran-Mantel-Haenszel 分析比较感兴趣的协变量。

结果:通过 5 分制对激素治疗的满意度进行平均和二分法处理,以衡量患者的满意度。

结论:理解患者的满意度和治疗目标将有助于在以患者为中心的性别肯定治疗中进行共同决策和咨询。

局限性:本研究的响应率较低,且仅包括有私人保险的受访者,限制了其普遍性。

相似文献

[1]
Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults.

J Sex Med. 2023-3-31

[2]
Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals.

J Sex Med. 2018-2-17

[3]
New insights into the goals of transgender male versus non-binary individuals considering metoidioplasty and phalloplasty gender-affirming surgery.

J Sex Med. 2025-4-8

[4]
Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.

J Sex Med. 2021-9

[5]
Clinical and sociodemographic characteristics as predictors for quality of life in transmasculine and transfeminine individuals receiving gender-affirming hormone therapy.

Soc Sci Med. 2024-4

[6]
Assessing Preferences of Facial Appearance in Transgender and Gender Nonbinary Patients.

Aesthetic Plast Surg. 2024-2

[7]
Shallow-depth vaginoplasty: preoperative goals, postoperative satisfaction, and why shallow-depth vaginoplasty should be offered as a standard feminizing genital gender-affirming surgery option.

J Sex Med. 2023-10-31

[8]
The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.

J Sex Med. 2020-11

[9]
Patient-Reported Outcomes After Genital Gender-Affirming Surgery With Versus Without Urethral Lengthening in Transgender Men.

J Sex Med. 2021-5

[10]
Transgender and Nonbinary Individuals' Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study.

Circ Cardiovasc Qual Outcomes. 2024-9

引用本文的文献

[1]
Endocrine issues in critically ill transgender patients: A narrative review.

World J Crit Care Med. 2025-9-9

[2]
Managing common dermatologic needs in transgender and gender-diverse adolescents.

Curr Pediatr Rep. 2024

[3]
Addressing Factors that Impact Sexual Well-Being and Intimacy in IBD Patients.

Curr Gastroenterol Rep. 2025-12

[4]
Systematic Review of Neovaginal Prolapse After Vaginoplasty in Trans Women.

Eur Urol Open Sci. 2024-7-13

[5]
Quality of life and level of satisfaction with pharmacotherapeutic follow-up in a transgender health center in Brazil.

Sci Rep. 2024-2-21

本文引用的文献

[1]
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Int J Transgend Health. 2022-9-6

[2]
Survey of Dermatologic Procedures in Transgender Adults.

Dermatol Surg. 2021-10-1

[3]
The uterus in transgender men.

Fertil Steril. 2021-10

[4]
Transgender patients: considerations for routine gynecologic care and cancer screening.

Int J Gynecol Cancer. 2020-12

[5]
Transgender Voice and Communication.

Otolaryngol Clin North Am. 2019-8

[6]
Dermatologic Conditions in Transgender Populations.

Endocrinol Metab Clin North Am. 2019-6

[7]
Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.

JBI Database System Rev Implement Rep. 2019-9

[8]
Assessing Patient Satisfaction Among Transgender Individuals Seeking Medical Services.

Ann Plast Surg. 2018-12

[9]
Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals.

J Sex Med. 2018-2-17

[10]
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

J Clin Endocrinol Metab. 2017-11-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索